ReviewDialogues in health2025
Meta-analysis of mortality burden due to Aluminum phosphide poisoning in India: A call for strong policy and decision making.
Review in Dialogues in health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Successful survival after severe aluminum phosphide poisoning complicated by cardiogenic shock, atrial fibrillation and severe metabolic acidosis: a case report.Journal of medical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Aluminum phosphide(AlP) insecticide is India's leading cause of poisoning-related mortality. Limited information is available about its mortality burden, common presentation type, and exposure(suicidal/accidental) characteristics. There exists no definite antidote for AlP poisoning management. The study was planned to systematically review the exact mortality burden, type of exposure- accidental/suicidal, commonest presentation in emergency department(ED), and gender difference in poison exposure, if any. Methods: We conducted comprehensive search in Scopus, PubMed, Web of Science, and Embase, and cross-referencing relevant articles from 1982 to 31 January 2025. Prospective, retrospective, and cross-sectional Indian studies that provided information on mortality data, common clinical presentation, and exposure type-accidental/suicidal were included. Study details- time to reach ED, duration of hospital-stay, average dose consumed, gender distribution in poison exposure, and other relevant information, were also assessed. Random-effects meta-analysis with DerSimonian & Laird estimator, meta-regression, and subgroup analyses were conducted using R. Results: Forty-two studies involving 3449 Indian patients were included in the analysis Conclusion: Death of every second patient with AlP poisoning in ED room underscores the urgent need for stringent regulatory measures to control its access in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.